No Detail Found!

Role of nalbuphine as an adjuvant to ropivacaine in supraclavicular block- a randomized control study

Author(s)
Vinod Kumar Yadav Teerthanker Mahaveer Medical College and Research Center, National Highway 24, Delhi Road, Pakwara, Uttar Pradesh (India)
Amit Kumar Choudhary Teerthanker Mahaveer Medical College and Research Center, National Highway 24, Delhi Road,Pakwara, Uttar Pradesh (India)
Mukesh Kumar Prasad Teerthanker Mahaveer Medical College and Research Center, National Highway 24, Delhi Road,Pakwara, Uttar Pradesh (India)
Gurdeep Singh Jheetay Teerthanker Mahaveer Medical College and Research Center, National Highway 24, Delhi Road, Pakwara, Uttar Pradesh (India)
Amber Kumar Teerthanker Mahaveer Medical College and Research Center, National Highway 24, Delhi Road, Pakwara, Uttar Pradesh (India)
Razi Shahid Teerthanker Mahaveer Medical College and Research Center, National Highway 24, Delhi Road, Pakwara, Uttar Pradesh (India)
Abstract
Nalbuphine is a strong analgesic with mixed k agonist and µ antagonist was studied several times as adjuvant to local anesthetics in spinal, epidural and local infiltration but very few studies on brachial plexus block. The aim of this study was to evaluate the effect of nalbuphine as an adjuvant to ropivacaine 0.75% in supraclavicular brachial plexus block.Methodology: In a prospective, double blind study of sixty patients undergoingelective upper limb surgeries were randomized into two groups. Group R - (n = 30), 29mL of 0.75% ropivacaine + 1 mL normal saline and in study Group N (n = 30), 29 mLof 0.75% ropivacaine + 1 mL (10 mg) nalbuphine were used for giving supraclavicularblock under Ultrasound (US) guidance. Parameters assessed were onset and durationof sensory and motor block, duration of analgesia, and any adverse events. Afteradministration of block with above drugs, the block characteristics were assessedevery 2 and 3 min till onset of complete blockade, then hourly till the effect of blockpersist. Data between the groups were analyzed using independent ttest with statisticalpackage for social science (SPSS) 21.0 software.Results: The demographic profile of the patients age, sex, weight, ASA gradewere comparable in both groups. There were no hemodynamic variations and nocomplication of technique or adverse effects due to nalbuphine occurred (p ? 0.05). The mean onset times of sensory blocks was 11.58 ± 3.56 vs. 10.84 ± 3.24 (p = 0.40) and onset times of motor block was 13.12 ± 4.98 vs. 11.23 ± 3.29 (p = 0.09) in Group R and Group N respectively. The differences were not statistically significant in both groups. The mean duration of sensory block [e.g. 512.52 ± 16.47 vs. 588.25 ± 19.63 min (p = 0.0001)] and motor block [467.66 ± 17.34 vs. 518.45 ± 16.65 min (p = 0.0001)] were significantly prolonged in Group R than in Group N. The mean duration of analgesia was significantly more in Group R than in Group N, e.g. 598.21 ± 19.33 vs. 705.39 ± 31.54 min (p < 0.0001) Conclusion: Nalbuphine significantly extends the duration of analgesia of brachial plexus block under supraclavicular approach when used with 0.75% ropivacaine and has no adverse effects.
Publication Details
Page(s) 186-191
DOI DOI not available
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 23, Issue: 2, Year: 2019

Request the full text from PASTIC

Keywords
Bupivacaine, Nalbuphine, Ultrasound guidance, Brachial plexus block, Supraclavicular approach
0

Citations

0

Downloads

44

Views